Medical Device News Magazine

Dr Waleed Brinjikj Joins MIVI Neuroscience as Medical Director

About Medical Device News Magazine

About Medical Device News Magazine. We are a digital publication founded in 2008 located in the United States.

Advertise with Medical Device News Magazine! Join Our #1 Family of Advertisers!

We pride ourselves on being the best-kept secret when it comes to distributing your news! Our unique digital approach enables us to circulate your...

Summation

  • He is extensively involved in stroke and neuroendovascular research, with more than 500 peer-reviewed papers and multiple industry and NIH grants, including for a study on improving revascularization techniques in stroke.

Dr Waleed Brinjikj is an internationally respected interventional neuroradiologist based in Rochester, Minn. He is extensively involved in stroke and neuroendovascular research, with more than 500 peer-reviewed papers and multiple industry and NIH grants, including for a study on improving revascularization techniques in stroke.

Most recently, Dr. Brinjikji was chief medical officer of Marblehead Medical, a Minnesota-based stroke company. He trained at top North American institutions including the University of Toronto and the Mayo Clinic.

As medical director, Dr. Brinjikji will provide MIVI with input and medical guidance across a wide spectrum of its activities, including original clinical research and studies, product design and development, and clinical and customer communications.

“We’re looking forward to Dr. Brinjikji joining our team at this exciting time,” said Bob Colloton, MIVI CEO. “His insights and experience will be invaluable as we continue to achieve our clinical and commercial milestones for our flagship products the Q Aspiration Catheter and DAISe Thrombectomy Device, and identify new business and development opportunities.”

Dr. Brinjikji commented, “The MIVI team shares my passion for improving the lives of patients who suffer an acute ischemic stroke.  I am looking forward to representing MIVI in the neurointerventional community and contributing to the advancement of novel technologies that advance stroke treatment.”

The Q Aspiration Catheter delivers unprecedented aspiration power by optimizing luminal radius and length.  It is CE-marked in Europe and under Investigational Device Exemption in the United States, where it is currently commercially available for distal access.   The DAISe Thrombectomy Device is designed to reduce distal embolization and improve patient outcomes.  It is currently available for investigational use only.

Medical Device News Magazinehttps://infomeddnews.com
Medical Device News Magazine provides breaking medical device / biotechnology news. Our subscribers include medical specialists, device industry executives, investors, and other allied health professionals, as well as patients who are interested in researching various medical devices. We hope you find value in our easy-to-read publication and its overall objectives! Medical Device News Magazine is a division of PTM Healthcare Marketing, Inc. Pauline T. Mayer is the managing editor.

Other News

HeartFlow Introduces Next Generation Interactive Plaque Analysis Platform to Assess Patient Risk in Suspected Coronary Artery Disease

The HeartFlow Plaque Analysis uses proprietary algorithms to analyze coronary CT angiogram (CCTA) scans, creating a personalized 3D model that quantifies and characterizes plaque volume in the coronary arteries, aiding risk assessment of coronary artery disease. The technology was introduced at the Society of Cardiovascular Computed Tomography (SCCT) Annual Scientific Meeting in Washington, D.C.

Ultrahuman Announces its App Store ‘PowerPlugs’ with the World’s First AFib Detection Technology on a Smart Ring

Recognizing each individual’s health journey is unique, PowerPlugs enable people to choose and focus on the aspects of their health that matter most. It’s designed for highly personalized health insights, ensuring that every individual can personalize their health tracking to their unique needs and goals.

VisionAir Solutions Celebrates Milestone and New Collaboration

This achievement marks VisionAir Solutions commitment to bringing technological innovation to pulmonary medicine. Since its acquisition by Theken Companies last year, VAS has over doubled its growth and continues to demonstrate industry adoption and the advantages of personalized healthcare.